Immunovant IMVT
NASDAQ IMVT
$28.23 -0.36 (-1.28%)
As of: Oct 21, 2026 · 2:50 PM EDT

Immunovant (IMVT) Net Margin (2022 - 2026)

Updated

Analysis

Immunovant (IMVT) Net Margin (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 21.86%
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn 21.27%
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 16.30%
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -134.51%
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn -1.65%
10 Immunovant 5.81 Bn 2.59 Bn - -2,159.61%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,159.61%
Mar 31, 2026 -1,835.35%
Dec 31, 2025 -2,074.54%
Sep 30, 2025 -2,257.35%
Jun 30, 2025 -1,903.31%
Mar 31, 2025 -1,545.43%
Dec 31, 2024 -2,420.96%
Sep 30, 2024 -1,796.79%
Jun 30, 2024 -1,213.79%
Mar 31, 2024 -898.90%
Dec 31, 2023 -575.60%
Sep 30, 2023 -1,642.27%
Jun 30, 2023 -1,818.87%
Mar 31, 2023 -1,707.82%
Dec 31, 2022 -2,147.66%
Sep 30, 2022 -4,153.21%
API Access

Immunovant Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMVT&period=max&api_key=YOUR_API_KEY